User:Kevin Dooley: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
Kevin Dooley (talk | contribs) No edit summary |
Kevin Dooley (talk | contribs) |
||
| (74 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{Template:Banta_Lab}} | |||
==Contact Info== | ==Contact Info== | ||
[[Image: | [[Image:Dooley.jpg|thumb|left|Kevin Dooley|150px]] | ||
I | *Kevin Dooley, PhD | ||
*Center for Engineering in Medicine │ Harvard Medical School | |||
*Massachusetts General Hospital │ Shriners Burns Hospital | |||
*51 Blossom Street, Room 250 | |||
*Boston, MA 02114 | |||
*kpdooley@mgh.harvard.edu | |||
<br /> | |||
I was a PhD student in [[User:Scott_Banta|Scott Banta's]] Protein and Metabolic Engineering Lab at [http://cheme.columbia.edu/ Columbia University] from 2009-2014. I am currently a postdoctoral fellow at the [http://cem.sbi.org/ Center for Engineering in Medicine]. | |||
<br /><br /><br /> | |||
==Education== | ==Education== | ||
<!--Include info about your educational background--> | <!--Include info about your educational background--> | ||
* 2014, PhD, Columbia University | * 2014, PhD, Chemical Engineering, Columbia University, New York, NY | ||
* 2009, MS, Manhattan College | * 2009, MS, Chemical Engineering, Manhattan College, Bronx, NY | ||
* 2008, BS, Manhattan College | * 2008, BS, Chemical Engineering, Manhattan College, Bronx, NY | ||
<br /> | |||
==Research | ==Research Interests== | ||
<!-- Feel free to add brief descriptions to your research interests as well --> | <!-- Feel free to add brief descriptions to your research interests as well --> | ||
The majority of my research in the Banta Lab focused on engineering a conformationally dynamic peptide isolated from a repeats-in-toxin (RTX) domain. This protein scaffold undergoes a reversible structural rearrangement in response to low millimolar concentrations of calcium from an intrinsically disordered state to a compact β-roll structure. We use this triggered conformational response to mediate a variety of molecular interactions for use in biotechnology systems, outlined below.<br /><br /> | |||
[[Image:Beta_Roll.tif]] | |||
*We have have rationally designed a leucine-rich RTX mutant capable of forming intermolecular cross-links for calcium-responsive proteinaceous hydrogel formation. In the absence of calcium, the designed hydrophobic interface is delocalized, thus mitigating the driving force for self-assembly.<br /> | |||
[[Image:Hydrogels.tif]] | |||
*RTX proteins are composed of a repeating nonamer calcium binding sequence. Often times for repeating protein scaffolds, consensus design is used to create synthetic peptides based on the amino acid frequency at each position. This can lead to higher levels of stability and recombinant expression. The genetic information can also be optimized for easier cloning and concatenation strategies. In exploring consensus design for the RTX protein, we discovered a synthetic sequence that undergoes a reversible phase change in response to calcium binding. We have used this sequence as a non-chromatographic protein purification tag, similar to the elastin like peptide (ELP) tags. By appending the β-roll tag (BRT) to a protein of interest, we can rapidly and efficiently separate the fusion from cell lysate (~ 10 minutes). We have added a protease site between the BRT and protein of interest allowing for the purification of untagged target by precipitation cycling. The image below shows the calcium specificity of the BRT. Fusions to GFP were prepared and incubated in a variety of ions (CaCl<sub>2</sub>, MgCl<sub>2</sub>, MnCl<sub>2</sub>, NaCl, (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, respectively). Note the near complete removal of GFP from solution in the first tube treated with calcium. | |||
<br /> | |||
[[Image:Precipitation.jpg]] | |||
<br /> | |||
<br /> | |||
*We are also currently evaluating the RTX protein as an alternative scaffold for evolving molecular recognition. The calcium-induced structural rearrangement can be used as a switch to turn a designed binding interface "on" and "off" thus creating an allosterically regulated binding domain. We have constructed an RTX library by randomizing 8 solvent exposed positions on the face of the folded β-roll structure and are currently selecting for affinity against several interesting targets using ribosome display technology. | |||
<br /> | |||
[[Image:Library.tif]] | |||
==Publications== | ==Publications== | ||
#Dooley K, Bulutoglu B, Banta S. (2014) Doubling the cross-linking interface of a rationally-designed beta roll peptide for calcium-dependent proteinaceous hydrogel formation. ''Biomacromolecules'' 15(10): 3617-24 | |||
#Banta, S Dooley, K, Shur, O. (2013) Replacing antibodies: Engineering new binding proteins. ''Annual review of biomedical engineering'' 15: 93-113 | |||
# | #Shur O, Dooley K, Blenner M, Baltimore M, Banta S. (2013) A designed, phase-changing RTX-based peptide for efficient bioseparations. ''Biotechniques'' 54(4): 197-206 | ||
# | #Dooley K, Kim YH, Lu HD, Tu R, Banta S. (2012) Engineering of an Environmentally Responsive Beta Roll Peptide for Use As a Calcium-Dependent Cross-Linking Domain for Peptide Hydrogel Formation. ''Biomacromolecules'' 13(6): 1758-64 | ||
# | #Wu J, Park JP, Dooley K, Cropek DM, West AC, Banta S. (2011) Rapid Development of New Protein Biosensors Utilizing Peptides Obtained via Phage Display. ''PLOS ONE'' 6: e24948 | ||
#Sahin A, Dooley K, Cropek DM, West AC, Banta S. (2011) A dual enzyme electrochemical assay for the detection of organophosphorus compounds using organophosphorus hydrolase and horseradish peroxidase. ''Sensors and Actuators B: Chemical'' 158: 353-60 | |||
Latest revision as of 12:46, 13 February 2015
Banta Lab
Protein and Metabolic Engineering
| Home | Lab Members | Publications | Research Interests | Courses | Pictures | Positions Available |
Contact Info
- Kevin Dooley, PhD
- Center for Engineering in Medicine │ Harvard Medical School
- Massachusetts General Hospital │ Shriners Burns Hospital
- 51 Blossom Street, Room 250
- Boston, MA 02114
- kpdooley@mgh.harvard.edu
I was a PhD student in Scott Banta's Protein and Metabolic Engineering Lab at Columbia University from 2009-2014. I am currently a postdoctoral fellow at the Center for Engineering in Medicine.
Education
- 2014, PhD, Chemical Engineering, Columbia University, New York, NY
- 2009, MS, Chemical Engineering, Manhattan College, Bronx, NY
- 2008, BS, Chemical Engineering, Manhattan College, Bronx, NY
Research Interests
The majority of my research in the Banta Lab focused on engineering a conformationally dynamic peptide isolated from a repeats-in-toxin (RTX) domain. This protein scaffold undergoes a reversible structural rearrangement in response to low millimolar concentrations of calcium from an intrinsically disordered state to a compact β-roll structure. We use this triggered conformational response to mediate a variety of molecular interactions for use in biotechnology systems, outlined below.
- We have have rationally designed a leucine-rich RTX mutant capable of forming intermolecular cross-links for calcium-responsive proteinaceous hydrogel formation. In the absence of calcium, the designed hydrophobic interface is delocalized, thus mitigating the driving force for self-assembly.
- RTX proteins are composed of a repeating nonamer calcium binding sequence. Often times for repeating protein scaffolds, consensus design is used to create synthetic peptides based on the amino acid frequency at each position. This can lead to higher levels of stability and recombinant expression. The genetic information can also be optimized for easier cloning and concatenation strategies. In exploring consensus design for the RTX protein, we discovered a synthetic sequence that undergoes a reversible phase change in response to calcium binding. We have used this sequence as a non-chromatographic protein purification tag, similar to the elastin like peptide (ELP) tags. By appending the β-roll tag (BRT) to a protein of interest, we can rapidly and efficiently separate the fusion from cell lysate (~ 10 minutes). We have added a protease site between the BRT and protein of interest allowing for the purification of untagged target by precipitation cycling. The image below shows the calcium specificity of the BRT. Fusions to GFP were prepared and incubated in a variety of ions (CaCl2, MgCl2, MnCl2, NaCl, (NH4)2SO4, respectively). Note the near complete removal of GFP from solution in the first tube treated with calcium.
- We are also currently evaluating the RTX protein as an alternative scaffold for evolving molecular recognition. The calcium-induced structural rearrangement can be used as a switch to turn a designed binding interface "on" and "off" thus creating an allosterically regulated binding domain. We have constructed an RTX library by randomizing 8 solvent exposed positions on the face of the folded β-roll structure and are currently selecting for affinity against several interesting targets using ribosome display technology.
Publications
- Dooley K, Bulutoglu B, Banta S. (2014) Doubling the cross-linking interface of a rationally-designed beta roll peptide for calcium-dependent proteinaceous hydrogel formation. Biomacromolecules 15(10): 3617-24
- Banta, S Dooley, K, Shur, O. (2013) Replacing antibodies: Engineering new binding proteins. Annual review of biomedical engineering 15: 93-113
- Shur O, Dooley K, Blenner M, Baltimore M, Banta S. (2013) A designed, phase-changing RTX-based peptide for efficient bioseparations. Biotechniques 54(4): 197-206
- Dooley K, Kim YH, Lu HD, Tu R, Banta S. (2012) Engineering of an Environmentally Responsive Beta Roll Peptide for Use As a Calcium-Dependent Cross-Linking Domain for Peptide Hydrogel Formation. Biomacromolecules 13(6): 1758-64
- Wu J, Park JP, Dooley K, Cropek DM, West AC, Banta S. (2011) Rapid Development of New Protein Biosensors Utilizing Peptides Obtained via Phage Display. PLOS ONE 6: e24948
- Sahin A, Dooley K, Cropek DM, West AC, Banta S. (2011) A dual enzyme electrochemical assay for the detection of organophosphorus compounds using organophosphorus hydrolase and horseradish peroxidase. Sensors and Actuators B: Chemical 158: 353-60
